Table 3 Chemotherapy type, chemoradiotherapy type (n = 39), and response to Chemotherapy (n = 27)
| Â | Disease status at diagnosis | All patients, n (%) | |
|---|---|---|---|
Localized/locoregional (n) | Metastatic (n) | ||
Chemotherapy type | Â | Â | Â |
 postoperative only | 12 | 0 | 12 (30.8) |
 both pre-and postoperative | 10 | 0 | 10 (25.6) |
 first-line chemotherapy | 0 | 5 | 5 (12.8) |
 radical chemoradiotherapy | 12 | 0 | 12 (30.8) |
Chemoradiotherapy type | Â | Â | Â |
 Sequential chemoradiation (SCRT) | 25 | 2 | 27 (69.2) |
 Concurrent chemoradiation (CCRT) | 9 | 3 | 12 (30.8) |
Response to chemotherapy | Â | Â | Â |
 CR | 1 | 0 | 1 (3.7) |
 PR | 9 | 4 | 13 (48.1) |
 SD | 10 | 2 | 12 (44.5) |
 PD | 1 | 0 | 1 (3.7) |